California State Teachers Retirement System Viracta Therapeutics, Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.87 - $5.0 $29,302 - $78,350	-15,670 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.23 - $4.76 $8,714 - $18,602	-3,908 Reduced 19.96%	15,670 $75,000
Q3 2021 Nov 15, 2021	SELL	$7.84 - $12.53 $238,367 - $380,962	-30,404 Reduced 60.83%	19,578 $157,000
Q2 2021 Aug 16, 2021	BUY	$7.55 - $12.95 $377,364 - $647,266	49,982 New	49,982 $567,000

Others Institutions Holding VIRX

# of Institutions

Shares Held

5.63M

Call Options Held

Put Options Held

Ken Griffin Citadel Advisors LLC | Chicago, Il

1.52M
Shares

$380,060
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

954K
Shares

$238,621
0.0% of portfolio
Samsara Bio Capital, LLC Palo Alto, CA

690K
Shares

$172,427
0.09% of portfolio
Stonepine Capital Management, LLC Bend, OR

500K
Shares

$125,000
0.07% of portfolio
Laurion Capital Management LP New York, NY

332K
Shares

$83,047
0.0% of portfolio

View Full List

About Viracta Therapeutics, Inc.

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $9.39M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

More about VIRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account